Idiopathic Generalized Epilepsy

• FDA approval · 2025-07-11
  FDA Approved: PERAMPANEL — Original Application (Novadoz Pharmaceuticals LLC)

  FDA approved the original ANDA for PERAMPANEL from Novadoz Pharmaceuticals LLC, making a generic version of perampanel available. This suppo…

• FDA approval · 2022-03-28
  FDA Approved: LEVETIRACETAM — Original Application (Solco Healthcare US, LLC)

  FDA approves Solco Healthcare US, LLC's generic levetiracetam through an Original Application (ANDA). The approval covers the same epilepsy …

• FDA approval · 2021-06-11
  FDA Approved: LEVETIRACETAM — Original Application (ScieGen Pharmaceuticals, Inc.)

  FDA approved the original application (ANDA) for LEVETIRACETAM by ScieGen Pharmaceuticals, authorizing the generic product.

• FDA approval · 2015-12-14
  FDA Approved: LEVETIRACETAM — Supplemental Application (Prasco Laboratories)

  The FDA approved a supplemental application for Levetiracetam from Prasco Laboratories, resulting in updated labeling for this antiepileptic…

• FDA approval · 2012-04-11
  FDA Approved: LEVETIRACETAM — Original Application (QUAGEN PHARMACEUTICALS LLC)

  FDA approved the original application for levetiracetam by Quagen Pharmaceuticals LLC, making a generic version of the antiepileptic availab…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2010-12-14
  FDA Approved: LEVETIRACETAM — Original Application (Cranbury Pharmaceuticals, LLC)

  FDA approves Cranbury Pharmaceuticals' original application for a generic levetiracetam, supporting its use for partial-onset seizures, myoc…

• FDA approval · 2010-12-13
  FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for levetiracetam from Aurobindo Pharma Limited, authorizing a generic Levetiracetam product under a…